While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table biotech stocks. This is just as innovative of sector as “regular” tech but it just hasn’t received the same fervor. That could soon change. With the usual suspects in the digital innovation arena soaring to new heights, the law of large numbers will eventually kick in. For investors to get the same rewards they’ve been used to will likely require ...